Atlas Trials

Non-small-cell Lung Cancer Patients

7 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Non-small-cell Lung Cancer Patients

RecordFirmDate
Randomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed Stage III Non-small-cell Lung Cancer (NSCLC) Pretreated With Chemoradiotherapy and Durvalumab (NCT05568212)Fondazione Ricerca Traslazionale2022-05-02
Cardiac Adverse Reactions Related to Immune Checkpoint Inhibitor in NSCLC Patients (NCT04473703)Shanghai Chest Hospital2020-08-01
Atezolizumab Versus Atezolizumab Plus Bevacizumab as First Line in NSCLC Patients (BEAT) (NCT03896074)Fondazione Ricerca Traslazionale2020-03-02
Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance (PIONeeR-BioMarkers (BM) Profiling) (NCT03493581)Assistance Publique Hopitaux De Marseille2018-03-08
Pembrolizumab (MK-3475) as Maintainance in Treated Patients With Unresectable Stage III NSCLC (NCT03379441)University of Turin, Italy2018-01-01
Analysis of Plasma Tumor DNA in Lung Cancer Patients (NCT01930474)Seoul National University Hospital2013-07-01
Early Changes in Positron Emissions Tomography (PET/CT) Scan as Predictors of Clinical Outcome in NSCLC Treated With EGFR Tyrosin Kinase Inhibitors (TKI) (NCT02043002)University of Aarhus2013-04-01

Track Non-small-cell Lung Cancer Patients automatically

Every clearance here is in the API, with alerts when new ones post.